Orchestra BioMed (OBIO) Misses Q3 EPS by 40c
Orchestra BioMed (NASDAQ: OBIO) reported Q3 EPS of ($0.40). Revenue for the quarter came in at $900 thousand.
For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.
Orchestra BioMed (NASDAQ: OBIO) reported Q3 EPS of ($0.40). Revenue for the quarter came in at $900 thousand.
For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.